5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside Inhibits Cancer Cell Proliferation in Vitro and in Vivo via AMP-activated Protein Kinase

This publication has 48 references indexed in Scilit:

• AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
  Published by Elsevier ,2004
• AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise
  Biochemical and Biophysical Research Communications, 2004
• 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase
  Journal of Neuroscience, 2004
• AMP-activated protein kinase, super metabolic regulator
  Biochemical Society Transactions, 2003
• Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation
  Oncogene, 2002
• AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling
  Journal of Biological Chemistry, 2002
• Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
  Nature, 2002
• Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
  Nature Genetics, 1998
• Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase
  FEBS Letters, 1994
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993